Post by
frankman on Jun 03, 2022 10:52am
Note this part of the nr
BioVaxys and Ohio State were recently invited by The Coalition for Epidemic Preparedness Innovations ("CEPI") to present their strategy for a pan-sarbecovirus vaccine to a panel of CEPI vaccine experts. Following this presentation, the Company and Ohio State were invited to return and deliver an update following completion of the animal studies. Based in Oslo, London, and Washington, DC, CEPI is a global foundation that directs public, private, and philanthropic funding towards vaccines targeting major unmet needs
Comment by
mba123ccu on Jun 03, 2022 11:17am
This seems to augur well for BIOV. If they can prove to and convince CEPI that they are on track with their research then a recommendation for funding may be available.
Comment by
Humanist on Jun 03, 2022 1:38pm
excellent highlight frankman, the fact they invited tem again to get an update shows strong interest and faith in their reserach. and for us investors, means biovayxys has agreat potential of reaching their end goal.. glta